Cancer and Leukemia Group B — Chicago, Illinois

Cancer and Leukemia Group B is a clinical research site located in Chicago, Illinois, United States 60606.

Crixeo Health Trust Score: 77/100 (FAIR). This profile has not yet been claimed by the site owner.

Cancer and Leukemia Group B has participated in 40 clinical trials.

Therapeutic areas: Adult Lymphocyte Depletion Hodgkin Lymphoma, Adult Lymphocyte Predominant Hodgkin Lymphoma, Adult Mixed Cellularity Hodgkin Lymphoma.

Sponsors: National Cancer Institute (NCI), Alliance for Clinical Trials in Oncology.

Sponsor Feasibility Report

Trust Score: 77/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Cancer and Leukemia Group B?

Cancer and Leukemia Group B has a Crixeo Trust Score of 77/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Cancer and Leukemia Group B conducted?

Cancer and Leukemia Group B has 40 clinical trials on record. Their work covers Adult Lymphocyte Depletion Hodgkin Lymphoma, Adult Lymphocyte Predominant Hodgkin Lymphoma, Adult Mixed Cellularity Hodgkin Lymphoma.

Is Cancer and Leukemia Group B accredited by Crixeo Health?

Yes — Cancer and Leukemia Group B holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Cancer and Leukemia Group B?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.